New Drug Approvals

Home | Pages | Archives

Synthetic approaches to the 2011 new drugs-Bioorganic & Medicinal Chemistry Vol 21, (11), 2013, Pg 2795–2825

June 13, 2013 3:04 pm

Volume 21, Issue 11, 1 June 2013, Pages 2795–2825

Synthetic approaches to the 2011 new drugs

• Hong X. Ding^a,, 
• Kevin K.-C. Liu^b,, 
• Subas M. Sakya^c,,
  
• Andrew C. Flick^{c, ,}
  
• Christopher J. O’Donnell^c,

• ^a Shenogen Pharma Group, Beijing, China
• ^b Pfizer Inc., San Diego, CA 92121, USA
• ^c Pfizer Inc., Groton, CT 06340, USA

• http://dx.doi.org/10.1016/j.bmc.2013.02.061,http://www.sciencedirect.com/science/article/pii/S0968089613002642
  

  Abstract

  New drugs are introduced to the market every year and each represents a privileged structure for its biological target. These new chemical entities (NCEs) provide insights into molecular recognition and also serve as leads for designing future new drugs. This review covers the synthesis of 26 NCEs that were launched in the world in 2011.

Posted by DR ANTHONY MELVIN CRASTO Ph.D

Categories: Uncategorized

Tags:

« Older Newer »

One Response to “Synthetic approaches to the 2011 new drugs-Bioorganic & Medicinal Chemistry Vol 21, (11), 2013, Pg 2795–2825”

1. Reblogged this on Med.Chem.in.Iceland.

   LikeLike

   By lindaedwards689 on June 14, 2013 at 12:57 pm

Leave a Reply

Mobile Site | Full Site

Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.